Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (451-460 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|March 30, 2022
Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemiaConnor Walsh, Anthony Hunter, Terra Lasho, et al.
Leukemia|March 30, 2022
RNAseqCNV: analysis of large-scale copy number variations from RNA-seq dataJan Bařinka, Zunsong Hu, Lu Wang, et al.
Leukemia|May 31, 2019
Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signalingMatthew Ho, Tianzeng Chen, Jiye Liu, et al.
Leukemia|September 13, 2018
COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemiaKristina Klupsch, Vanessa Baeriswyl, Roland Scholz, et al.
Leukemia|September 13, 2018
Downregulating Notch counteracts KrasGuangyao Kong, Xiaona You, Zhi Wen, et al.
Leukemia|March 23, 1999
Polycythemia vera megakaryocytes but not megakaryocytes from normal controls and patients with smokers polyglobuly spontaneously express IL-6 and IL-6R and secrete IL-6C Wickenhauser, J Thiele, J Lorenzen, et al.
Leukemia|March 23, 1999
MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1R Sood, A Talwar-Trikha, S R Chakrabarti, et al.
Leukemia|March 23, 1999
Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosisC Posovszky, C Friesen, I Herr, et al.
Leukemia|March 23, 1999
Bone morphogenetic protein 9 is a potent synergistic factor for murine hemopoietic progenitor cell generation and colony formation in serum-free culturesR E Ploemacher, L J Engels, A E Mayer, et al.
Leukemia|March 23, 1999
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, T E Witzig, et al.
Pageof 1,398

Showing results (451-460 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|March 30, 2022
Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemiaConnor Walsh, Anthony Hunter, Terra Lasho, et al.
Leukemia|March 30, 2022
RNAseqCNV: analysis of large-scale copy number variations from RNA-seq dataJan Bařinka, Zunsong Hu, Lu Wang, et al.
Leukemia|May 31, 2019
Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signalingMatthew Ho, Tianzeng Chen, Jiye Liu, et al.
Leukemia|September 13, 2018
COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemiaKristina Klupsch, Vanessa Baeriswyl, Roland Scholz, et al.
Leukemia|September 13, 2018
Downregulating Notch counteracts KrasGuangyao Kong, Xiaona You, Zhi Wen, et al.
Leukemia|March 23, 1999
Polycythemia vera megakaryocytes but not megakaryocytes from normal controls and patients with smokers polyglobuly spontaneously express IL-6 and IL-6R and secrete IL-6C Wickenhauser, J Thiele, J Lorenzen, et al.
Leukemia|March 23, 1999
MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1R Sood, A Talwar-Trikha, S R Chakrabarti, et al.
Leukemia|March 23, 1999
Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosisC Posovszky, C Friesen, I Herr, et al.
Leukemia|March 23, 1999
Bone morphogenetic protein 9 is a potent synergistic factor for murine hemopoietic progenitor cell generation and colony formation in serum-free culturesR E Ploemacher, L J Engels, A E Mayer, et al.
Leukemia|March 23, 1999
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, T E Witzig, et al.
Pageof 1,398